Company intelligence / Profile preview

Amatsigroup

Fontenilles, Occitanie, France

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Contributed to development and registration of over 30 drugs in human health clinical trials and more than 20 in animal health; broad offering from preclinical to commercial phases

Modalities: BiologicSmall moleculeVaccinePeptidesRecombinant protein
Industry: Contract Research Organization

Partnerships

Acquired Q-Biologicals (spin-off from VIB and Ghent University)clients include pharmaceutical laboratories and biotech companies

Beyond the preview

Go deeper on Amatsigroup.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amatsigroup.

Explore the full profile